Detalhe da pesquisa
1.
A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-GuérinâNaïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder.
J Urol
; : 101097JU0000000000003977, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653234
2.
Environmental impact of single-use and reusable flexible cystoscopes.
BJU Int
; 131(5): 617-622, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515438
3.
Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival.
J Urol
; 207(1): 77-85, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445890
4.
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
BJU Int
; 127(3): 311-317, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772468
5.
Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers.
World J Urol
; 39(8): 2869-2874, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370079
6.
Reply by Authors.
J Urol
; : 101097JU0000000000004017, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713596
7.
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.
Int J Urol
; 26(5): 532-542, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943578
8.
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Letter.
J Urol
; 207(2): 476-477, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694151
9.
Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study.
Urol Oncol
; 42(3): 71.e9-71.e18, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278631
10.
Salpingectomy for ovarian cancer prevention: Video education for the surgeon.
Gynecol Oncol Rep
; 53: 101368, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584804
11.
Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder.
Clin Genitourin Cancer
; 21(6): 631-638.e1, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336703
12.
Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis.
Tomography
; 9(5): 1734-1744, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736991
13.
Clinician's commentary: Atypia in urinary tract cytology specimens.
Diagn Cytopathol
; 50(4): 184-185, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411464
14.
Differential changes in self-reported quality of life in elderly populations after diagnosis of a genitourinary malignancy.
Urol Oncol
; 40(10): 455.e1-455.e10, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008253
15.
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage.
Clin Genitourin Cancer
; 20(1): 60-68, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896022
16.
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort.
Clin Genitourin Cancer
; 20(4): e276-e282, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410826
17.
Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma.
Eur Urol Open Sci
; 43: 28-34, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353070
18.
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
Urology
; 163: 164-176, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995562
19.
Penile sarcomatoid urothelial carcinoma: A case report.
Urol Case Rep
; 38: 101706, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34703768
20.
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC).
Clin Genitourin Cancer
; 19(4): e206-e215, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773937